LFA-1 (CD11a) as a Therapeutic Target
Open Access
- 1 January 2006
- journal article
- Published by Elsevier BV in American Journal of Transplantation
- Vol. 6 (1), 27-36
- https://doi.org/10.1111/j.1600-6143.2005.01158.x
Abstract
No abstract availableKeywords
This publication has 85 references indexed in Scilit:
- Efalizumab: an overviewJournal of the American Academy of Dermatology, 2003
- Interferon-?? is not a universal requirement for islet allograft survival1Transplantation, 2002
- Anti-lymphocyte function-associated antigen-1 monoclonal antibody inhibits CD40 ligand-independent immune responses and prevents chronic vasculopathy in CD40 ligand-deficient mice1Transplantation, 2002
- Synaptic pattern formation during cellular recognitionProceedings of the National Academy of Sciences of the United States of America, 2001
- The Immunological Synapse: A Molecular Machine Controlling T Cell ActivationScience, 1999
- Anti-LFA-1α reduces the dose of cyclosporin A needed to produce immunosuppression in heterotopic cardiac transplanted ratsThe Journal of Heart and Lung Transplantation, 1999
- Induction of donor-specific tolerance to rat nerve allografts with portal venous donor alloantigen and anti-ICAM-1/LFA-1 monoclonal antibodiesSurgery, 1998
- Molecular Mechanisms of Lymphocyte Homing to Peripheral Lymph NodesThe Journal of Experimental Medicine, 1998
- A RANDOMIZED MULTICENTER TRIAL COMPARING LEUKOCYTE FUNCTION-ASSOCIATED ANTIGEN-1 MONOCLONAL ANTIBODY WITH RABBIT ANTITHYMOCYTE GLOBULIN AS INDUCTION TREATMENT IN FIRST KIDNEY TRANSPLANTATIONSTransplantation, 1996
- Prevention of fetal bowel allograft rejection by combined treatment with anti-ICAM-1 and anti-LFA-1 antibodiesJournal of Pediatric Surgery, 1995